Clinical Trial Update: Genotypic Resistance Guided Versus Susceptibility Testing Guided Therapy for the First-line Eradication of H. Pylori [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing genotypic resistance-guided therapy to susceptibility-tested guided therapy for first-line eradication of Helicobacter pylori.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN